174 related articles for article (PubMed ID: 6134430)
1. Sodium valproate and biperiden in neuroleptic-induced akathisia, parkinsonism and hyperkinesia. A double-blind cross-over study with placebo.
Friis T; Christensen TR; Gerlach J
Acta Psychiatr Scand; 1983 Mar; 67(3):178-87. PubMed ID: 6134430
[No Abstract] [Full Text] [Related]
2. No difference in the effect of biperiden and amantadine on parkinsonian- and tardive dyskinesia-type involuntary movements: a double-blind crossover, placebo-controlled study in medicated chronic schizophrenic patients.
Silver H; Geraisy N; Schwartz M
J Clin Psychiatry; 1995 Apr; 56(4):167-70. PubMed ID: 7713856
[TBL] [Abstract][Full Text] [Related]
3. A comparison of biperiden hydrochloride (Akineton) and benzhexol (Artane) in the treatment of drug-induced Parkinsonism.
Magnus RV
J Int Med Res; 1980; 8(5):343-6. PubMed ID: 7418951
[TBL] [Abstract][Full Text] [Related]
4. Successful clonazepam treatment of neuroleptic-induced akathisia in older adolescents and young adults: a double-blind, placebo-controlled study.
Kutcher S; Williamson P; MacKenzie S; Marton P; Ehrlich M
J Clin Psychopharmacol; 1989 Dec; 9(6):403-6. PubMed ID: 2574191
[TBL] [Abstract][Full Text] [Related]
5. Effect of different neuroleptics in tardive dyskinesia and parkinsonism. A video-controlled multicenter study with chlorprothixene, perphenazine, haloperidol and haloperidol + biperiden. Nordic Dyskinesia Study Group.
Psychopharmacology (Berl); 1986; 90(4):423-9. PubMed ID: 2880362
[TBL] [Abstract][Full Text] [Related]
6. Biperiden (Akineton): effective prophylactic and therapeutic anti-parkinsonian agent.
Kline NS; Mason BT; Winick L
Curr Ther Res Clin Exp; 1974 Aug; 16(8):838-43. PubMed ID: 4155670
[No Abstract] [Full Text] [Related]
7. The effectiveness of intramuscular biperiden in acute akathisia: a double-blind, randomized, placebo-controlled study.
Baskak B; Atbasoglu EC; Ozguven HD; Saka MC; Gogus AK
J Clin Psychopharmacol; 2007 Jun; 27(3):289-94. PubMed ID: 17502777
[TBL] [Abstract][Full Text] [Related]
8. Movement disorders in patients with coexistent neuroleptic-induced tremor and tardive dyskinesia: EMG and pharmacological study.
Rondot P; Bathien N
Adv Neurol; 1987; 45():361-6. PubMed ID: 2881446
[No Abstract] [Full Text] [Related]
9. Usefulness of antiparkinsonian drugs during neuroleptic treatment and the effect of clonazepam on akathisia and parkinsonism occurred after antiparkinsonian drug withdrawal: a double-blind study.
Horiguchi J; Nishimatsu O
Jpn J Psychiatry Neurol; 1992 Sep; 46(3):733-9. PubMed ID: 1362592
[TBL] [Abstract][Full Text] [Related]
10. Tardive dyskinesia during and following treatment with haloperidol, haloperidol + biperiden, thioridazine, and clozapine.
Gerlach J; Simmelsgaard H
Psychopharmacology (Berl); 1978 Oct; 59(2):105-12. PubMed ID: 103110
[No Abstract] [Full Text] [Related]
11. Biperiden withdrawal in schizophrenic inpatients receiving long-term antipsychotic medication.
Wada Y; Koshino Y; Yamaguchi N
Clin Neuropharmacol; 1987 Aug; 10(4):370-5. PubMed ID: 2902920
[TBL] [Abstract][Full Text] [Related]
12. Electroconvulsive therapy for persistent neuroleptic-induced akathisia and parkinsonism: a case report.
Hermesh H; Aizenberg D; Friedberg G; Lapidot M; Munitz H
Biol Psychiatry; 1992 Feb; 31(4):407-11. PubMed ID: 1348431
[TBL] [Abstract][Full Text] [Related]
13. The relationship between parkinsonism and tardive dyskinesia.
Gerlach J
Am J Psychiatry; 1977 Jul; 134(7):781-4. PubMed ID: 869056
[TBL] [Abstract][Full Text] [Related]
14. The "neuroleptic" antipsychotic drugs. 2. Neurologic side effects.
Baldessarini RJ
Postgrad Med; 1979 Apr; 65(4):123-8. PubMed ID: 34142
[TBL] [Abstract][Full Text] [Related]
15. Inefficacy of propranolol in attenuation of drug-induced parkinsonian tremor.
Metzer WS; Paige SR; Newton JE
Mov Disord; 1993; 8(1):43-6. PubMed ID: 8093548
[TBL] [Abstract][Full Text] [Related]
16. Legal aspects of neuroleptic-induced movement disorders.
Wettstein RM
Leg Med; 1985; ():117-79. PubMed ID: 2872562
[No Abstract] [Full Text] [Related]
17. Neuroleptic-induced Parkinson's syndrome: clinical features and results of treatment with levodopa.
Hardie RJ; Lees AJ
J Neurol Neurosurg Psychiatry; 1988 Jun; 51(6):850-4. PubMed ID: 2900293
[TBL] [Abstract][Full Text] [Related]
18. Sodium valproate in the treatment of levodopa-induced dyskinesia.
Price PA; Parkes JD; Marsden CD
J Neurol Neurosurg Psychiatry; 1978 Aug; 41(8):702-6. PubMed ID: 355601
[TBL] [Abstract][Full Text] [Related]
19. The effect of sodium valproate on tardive dyskinesia--revisited.
Fisk GG; York SM
Br J Psychiatry; 1987 Apr; 150():542-6. PubMed ID: 3117156
[TBL] [Abstract][Full Text] [Related]
20. Reduction in neuroleptic-induced movement disorders after a switch to quetiapine in patients with schizophrenia.
Cortese L; Caligiuri MP; Williams R; Schieldrop P; Manchanda R; Malla A; Harricharan R
J Clin Psychopharmacol; 2008 Feb; 28(1):69-73. PubMed ID: 18204344
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
